Suppr超能文献

影响偶发性甲状腺微小乳头状癌患者预后的因素。

Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma.

作者信息

Mantinan Beatriz, Rego-Iraeta Antonia, Larrañaga Alejandra, Fluiters Enrique, Sánchez-Sobrino Paula, Garcia-Mayor Ricardo V

机构信息

Endocrine, Diabetes, Nutrition and Metabolism Department, University Hospital of Vigo, P.O. Box 1691, Plaza de Compostela 3, 36201 Vigo, Spain.

出版信息

J Thyroid Res. 2012;2012:469397. doi: 10.1155/2012/469397. Epub 2012 Oct 2.

Abstract

Objective. To analyze some factors that could influence the outcome of patients with PTMC. Material and Methods. This is a longitudinal observational study. All patients diagnosed and treated for papillary thyroid microcarcinoma at the University Hospital of Vigo, between January 1994 and December 2003, were included in the present study. Demographic characteristics, tumour characteristics, TNM stage, rate of recurrence, and treatment with (131)I were the study variables. Results. Ninety-one patients (75 females) with an average age of 47.7 ± 13.4 years, range 19-81, were studied. Initial tumour staging was T1 in 90 patients and T4a in 1 case. Initial lymph node involvement was present in 4 cases (4.4%). We only found one case with distant metastases at diagnosis. Postsurgical evaluation of thyroid specimens revealed that 28 (30.7%) tumours were multifocal. The average size of the tumour was 0.44 ± 0.25 cm, range 0.1-1. Univariate analysis reveals a statistically significant association between tumour multifocality and postsurgical (131)I therapy with the recurrence rate. In the multivariate analysis only multifocality (P = 0.037, HR 5.7) was a significant risk factor for the recurrence rate. Conclusions. Our results indicate that tumour multifocality is an independent predictor of relapse but neither the tumour size nor postsurgical (131)I therapy.

摘要

目的。分析一些可能影响甲状腺微小乳头状癌(PTMC)患者预后的因素。材料与方法。这是一项纵向观察性研究。纳入了1994年1月至2003年12月期间在维戈大学医院诊断并接受治疗的所有甲状腺微小乳头状癌患者。人口统计学特征、肿瘤特征、TNM分期、复发率以及¹³¹I治疗情况为研究变量。结果。共研究了91例患者(75例女性),平均年龄为47.7±13.4岁,年龄范围19 - 81岁。初始肿瘤分期为T1期的患者有90例,T4a期1例。初始有4例(4.4%)出现淋巴结受累。诊断时仅发现1例有远处转移。对甲状腺标本的术后评估显示,28例(30.7%)肿瘤为多灶性。肿瘤平均大小为0.44±0.25 cm,范围0.1 - 1 cm。单因素分析显示肿瘤多灶性及术后¹³¹I治疗与复发率之间存在统计学显著关联。多因素分析中,只有多灶性(P = 0.037,HR 5.7)是复发率的显著危险因素。结论。我们的结果表明,肿瘤多灶性是复发的独立预测因素,而肿瘤大小及术后¹³¹I治疗并非如此。

相似文献

1
Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma.
J Thyroid Res. 2012;2012:469397. doi: 10.1155/2012/469397. Epub 2012 Oct 2.
4
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Eur J Clin Invest. 2012 Jun;42(6):657-64. doi: 10.1111/j.1365-2362.2011.02633.x. Epub 2011 Dec 14.
5
Risk factors associated with intrathyroid extension of thyroid microcarcinomas.
Langenbecks Arch Surg. 2018 Aug;403(5):615-622. doi: 10.1007/s00423-018-1680-3. Epub 2018 May 17.
6
Significance of multifocality in papillary thyroid carcinoma.
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
8
Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases.
Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Aug;129(4):175-8. doi: 10.1016/j.anorl.2011.11.003. Epub 2012 Apr 3.

引用本文的文献

2
Prevalence and Predictors of Malignancy in Contralateral Thyroid Lobe in Patients Undergoing Completion Thyroidectomy.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2053-2060. doi: 10.1007/s12070-020-02009-2. Epub 2020 Jul 31.
6
Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly.
J Cancer. 2018 Jan 1;9(2):256-262. doi: 10.7150/jca.22700. eCollection 2018.
8
A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma.
Oncotarget. 2017 Jan 24;8(4):7148-7156. doi: 10.18632/oncotarget.12698.
9
Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area.
J Thyroid Res. 2016;2016:1784397. doi: 10.1155/2016/1784397. Epub 2016 Feb 2.

本文引用的文献

1
Approach to the patient with incidental papillary microcarcinoma.
J Clin Endocrinol Metab. 2010 Aug;95(8):3586-92. doi: 10.1210/jc.2010-0698.
2
An observational trial for papillary thyroid microcarcinoma in Japanese patients.
World J Surg. 2010 Jan;34(1):28-35. doi: 10.1007/s00268-009-0303-0.
4
Recurrence after treatment of micropapillary thyroid cancer.
Thyroid. 2009 Oct;19(10):1043-8. doi: 10.1089/thy.2008.0407.
6
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Surgery. 2008 Dec;144(6):980-7; discussion 987-8. doi: 10.1016/j.surg.2008.08.035.
7
Papillary thyroid microcarcinoma: prognostic factors and treatment.
J Surg Oncol. 2008 Mar 1;97(3):221-5. doi: 10.1002/jso.20935.
8
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid.
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):240-8. doi: 10.1038/ncpendmet0428.
10
Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series.
Endocr Pathol. 2006 Summer;17(2):165-73. doi: 10.1385/ep:17:2:165.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验